Estee Lauder Companies Inc (EL) Stock AnalysisELStock AnalysisEstee Lauder Companies Inc

The Estee Lauder Companies Inc. is a manufacturer, marketer and seller of skin care, makeup, fragrance and hair care products. Its products are sold in over 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown Cosmetics, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty. It is a license for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, facial masks, body care, sun care products and others. Its makeup products include foundations, powders, concealers and setting sprays, lipsticks, lip liners and lip glosses, and mascaras, eyeshadows and eyeliners. It operates in the Consumer Non-Cyclicals sector (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS industry).

Estee Lauder is currently priced at $103.39, with a forward P/E ratio of 32.36, indicating high valuation. The RSI is at 68.08, suggesting it is nearing overbought territory. While the company recently beat earnings expectations and raised its operating margin outlook, insider selling has increased by 38,210.71%, which is a significant red flag. Therefore, it may be prudent to hold rather than buy at this time.

24 analysts cover EL: 19 rate it Buy, 5 Hold and 0 Sell. The average price target is 106.76.